ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för AS1842856. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

19 träffar

Bibliografisk träff 2019-12-23

FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis.

Wang D, Wang Y, Zou X, Shi Y, Liu Q, Huyan T, Su J, Wang Q, Zhang F, Li X, Tie L.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/bph.14878

Bibliografisk träff 2019-09-27

FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice.

Liu YZ, Peng W, Chen JK, Su WJ, Yan WJ, Wang YX, Jiang CL.

PeerJ · research-article; journal article · DOI 10.7717/peerj.7668

Bibliografisk träff 2019-09-25

FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma.

Gehringer F, Weissinger SE, Swier LJ, Möller P, Wirth T, Ushmorov A.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers11101427

Bibliografisk träff 2019-07-01

Loss of microRNA-27a induces cardiac dysfunction through activating FoxO1.

Qin XD, Liu L.

Eur Rev Med Pharmacol Sci · journal article · DOI 10.26355/eurrev_201907_18340

Bibliografisk träff 2019-05-30

Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway.

Zhu Z, Li J, Zhang X.

BMC Complement Altern Med · research-article; journal article · DOI 10.1186/s12906-019-2526-4

Bibliografisk träff 2019-05-11

Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt/FOXO1 signalling cascade.

Majumder S, Ren L, Pushpakumar S, Sen U.

Cell Signal · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.cellsig.2019.05.003

Bibliografisk träff 2019-05-01

FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction.

Roux A, Leroy H, De Muylder B, Bracq L, Oussous S, Dusanter-Fourt I, Chougui G, Tacine R, Randriamampita C, Desjardins D, Le Grand R, Bouillaud F, Benichou S, Margottin-Goguet F, Cheynier R, Bismuth G, Mangeney M.

PLoS Pathog · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.ppat.1007669

Bibliografisk träff 2019-01-17

FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Gao R, Li T, Tan B, Ramos da Silva S, Jung JU, Feng P, Gao SJ.

J Virol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1128/jvi.01681-18

Bibliografisk träff 2019-01-03

Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury.

Artham S, Gao F, Verma A, Alwhaibi A, Sabbineni H, Hafez S, Ergul A, Somanath PR.

Pharmacol Res · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.phrs.2019.01.006

Bibliografisk träff 2017-11-20

FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells.

Yu F, Wei R, Yang J, Liu J, Yang K, Wang H, Mu Y, Hong T.

Exp Cell Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yexcr.2017.11.022

Bibliografisk träff 2017-09-28

Involvement of nutrients and nutritional mediators in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression.

Rescigno T, Capasso A, Tecce MF.

J Cell Physiol · research support, non-u.s. gov't; journal article · DOI 10.1002/jcp.26177

Bibliografisk träff 2017-07-07

FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.

Gopal K, Saleme B, Al Batran R, Aburasayn H, Eshreif A, Ho KL, Ma WK, Almutairi M, Eaton F, Gandhi M, Park EA, Sutendra G, Ussher JR.

Am J Physiol Heart Circ Physiol · journal article · DOI 10.1152/ajpheart.00191.2017

Bibliografisk träff 2017-02-13

TNF-α decreases lipoprotein lipase activity in 3T3-L1 adipocytes by up-regulation of angiopoietin-like protein 4.

Makoveichuk E, Vorrsjö E, Olivecrona T, Olivecrona G.

Biochim Biophys Acta Mol Cell Biol Lipids · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbalip.2017.02.005

Bibliografisk träff 2016-06-03

FoxO1 antagonist suppresses autophagy and lipid droplet growth in adipocytes.

Liu L, Zheng LD, Zou P, Brooke J, Smith C, Long YC, Almeida FA, Liu D, Cheng Z.

Cell Cycle · report; journal article · DOI 10.1080/15384101.2016.1192732

Bibliografisk träff 2016-01-01

FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?

Pandey A, Kumar GS, Kadakol A, Malek V, Gaikwad AB.

Curr Diabetes Rev · review; journal article · DOI 10.2174/1573399811666150804104858

Bibliografisk träff 2015-10-26

Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.

Zhang L, Ji QH, Ruge F, Lane C, Morris D, Tee AR, Dayan CM, Ludgate M.

J Clin Endocrinol Metab · research support, non-u.s. gov't; journal article · DOI 10.1210/jc.2015-2932

Bibliografisk träff 2014-05-05

Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R/PI3K/AKT signaling pathway in hepatocytes.

Ju SJ, Zhao Y, Chang X, Guo L.

Int J Mol Med · research support, non-u.s. gov't; journal article · DOI 10.3892/ijmm.2014.1769

Bibliografisk träff 2014-01-01

Targeting FoxO1 with AS1842856 suppresses adipogenesis.

Zou P, Liu L, Zheng L, Liu L, Stoneman RE, Cho A, Emery A, Gilbert ER, Cheng Z.

Cell Cycle · research support, non-u.s. gov't; report; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.4161/15384101.2014.965977

Bibliografisk träff 2010-08-24

Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.

Nagashima T, Shigematsu N, Maruki R, Urano Y, Tanaka H, Shimaya A, Shimokawa T, Shibasaki M.

Mol Pharmacol · journal article · DOI 10.1124/mol.110.065714